search
Back to results

Repetitive Transcranial Magnetic Stimulation (rTMS) and P50 Evoked Potential Component (rTMS-P50)

Primary Purpose

Depression, Schizophrenia

Status
Completed
Phase
Phase 2
Locations
France
Study Type
Interventional
Intervention
high-frequency of repetitive transcranial magnetic stimulation (rTMS)
low frequency of repetitive transcranial magnetic stimulation (rTMS)
Sponsored by
University Hospital, Caen
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Depression focused on measuring rTMS, P50, inhibitory, facilitatory, physiological process, brain changes

Eligibility Criteria

18 Years - 60 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • healthy subjects, right-handed, aged from 18 to 60 years
  • written consent
  • with social security

Exclusion Criteria:

  • pregnancy, breastfeeding
  • brain tumor or epilepsy
  • psychiatric, neurological or ear-nose-throat disorders, current or past
  • healthy subjects with psychotropic drugs or with substance abuses
  • healthy subjects with tabacco weaning
  • protected major with tutor
  • counter-indication to MRI and rTMS

Sites / Locations

  • Caen University Hospital, department of psychiatry and explorations fonctionnelles neurologiques

Arms of the Study

Arm 1

Arm 2

Arm Type

Other

Other

Arm Label

high frequency rTMS

low frequency rTMS

Arm Description

Outcomes

Primary Outcome Measures

P50 Ratio Stimulation 2/S stimulation 1

Secondary Outcome Measures

Full Information

First Posted
October 19, 2011
Last Updated
June 7, 2013
Sponsor
University Hospital, Caen
search

1. Study Identification

Unique Protocol Identification Number
NCT01466439
Brief Title
Repetitive Transcranial Magnetic Stimulation (rTMS) and P50 Evoked Potential Component
Acronym
rTMS-P50
Official Title
Evaluation of Effect of Low and High-frequencies of Repetitive Transcranial Magnetic Stimulation (rTMS) by the Suppression of P50 Evoked Potential Component (rTMS-P50)
Study Type
Interventional

2. Study Status

Record Verification Date
June 2013
Overall Recruitment Status
Completed
Study Start Date
May 2011 (undefined)
Primary Completion Date
June 2012 (Actual)
Study Completion Date
June 2013 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Caen

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The repetitive transcranial magnetic stimulation (rTMS) is a recent technique that has demonstrated its efficiency in both depression and schizophrenia. However if its efficiency has been recognized by the scientific community and the clinicians, its action on neurons and cerebral networks remains debated. In the motor regions, the different rTMS studies generally use frequencies of stimulation of 1 to 40 Hz with differential effects; the low frequencies being associated with an inhibitory effect whereas highest frequencies have rather some facilitator effects as attested by the motor responses. What is valid for the motor system is not however necessarily applicable to other cerebral regions that have different neuronal organizations. If it is easy to observe these opposite effects of rTMS on the motor system (presence or absence of movements), these potential effects on more integrated cortex involved in high level functions have not been proved. One of the possibilities to interpret the effects of the rTMS in no-motor cerebral regions would be to study the modifications of the EEG before and after rTMS and to see if a differential effect of the high and low frequencies of stimulation exists. Up to now, the studies having coupled these two techniques have observed modifications of the brain electric activity only during some seconds to minutes after rTMS, what appears in contrast with the clinical effects observed after a long delay (several days). The contribution of our research resides in the use of the paradigm of suppression of P50 evoked potential component before and after rTMS tested with low and high frequencies of stimulation. This paradigm consists in two identical auditory stimuli presented at a very short interval (generally 500 milliseconds), the second sound generating a P50 wave of weaker amplitude than the first or being completely abolished in healthy subjects. However, this effect that has been well studied could result from an inhibitory action due to the gabaergic interneurons on the pyramidal neurons of the cortex. Thus, the investigators hypothesize that high frequency rTMS would have a facilitator effect on temporal lobe and so would induce no suppression of the P50 after-rTMS whereas low frequency rTMS would induce an inhibitory effect marked by a greater suppression of the P50. Methods: 30 healthy subjects (of which 16 women) will be included after written consent. They will receive after randomization 2 sessions of rTMS in cross over at 1Hz and 20Hz at 30 days interval. An EEG and a P50 evoked potential will be done before and after rTMS. The site of stimulation will be determined by neuronavigation and will correspond to the maximal activation cluster generated by a language task during functional magnetic resonance imaging. The main judgment criterion is the S2/S1 ratio of the P50. The potential secondary effects will be evaluated (UKU adapted). The secondary criteria are the comparisons before and after rTMS of EEG spectrums in the alpha, beta and gamma bands.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Depression, Schizophrenia
Keywords
rTMS, P50, inhibitory, facilitatory, physiological process, brain changes

7. Study Design

Primary Purpose
Basic Science
Study Phase
Phase 2
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
30 (Actual)

8. Arms, Groups, and Interventions

Arm Title
high frequency rTMS
Arm Type
Other
Arm Title
low frequency rTMS
Arm Type
Other
Intervention Type
Procedure
Intervention Name(s)
high-frequency of repetitive transcranial magnetic stimulation (rTMS)
Intervention Description
frequency of stimulation of 20 Hz
Intervention Type
Procedure
Intervention Name(s)
low frequency of repetitive transcranial magnetic stimulation (rTMS)
Intervention Description
frequency of stimulation of 1 Hz
Primary Outcome Measure Information:
Title
P50 Ratio Stimulation 2/S stimulation 1
Time Frame
day of stimulation (day 1)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: healthy subjects, right-handed, aged from 18 to 60 years written consent with social security Exclusion Criteria: pregnancy, breastfeeding brain tumor or epilepsy psychiatric, neurological or ear-nose-throat disorders, current or past healthy subjects with psychotropic drugs or with substance abuses healthy subjects with tabacco weaning protected major with tutor counter-indication to MRI and rTMS
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Pr Sonia Dollfus, MD, PhD
Organizational Affiliation
University Hospital, Caen
Official's Role
Principal Investigator
Facility Information:
Facility Name
Caen University Hospital, department of psychiatry and explorations fonctionnelles neurologiques
City
Caen
Country
France

12. IPD Sharing Statement

Learn more about this trial

Repetitive Transcranial Magnetic Stimulation (rTMS) and P50 Evoked Potential Component

We'll reach out to this number within 24 hrs